Clinical Trial Update: Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME) [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate safety, efficacy, and cost-efficacy of ranibizumab as monotherapy or with laser for diabetic macular edema; results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2014-10-23